Popular weight loss drugs linked to rare but severe stomach ... - NBC News
People who take popular drugs for weight loss, like Ozempic or Wegovy, may be at an increased risk of severe stomach issues, research published Thursday finds.
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · Hannah Beier/Reuters. CNN — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 …
May 22, 2024 · A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four years. The medication shows significant cardiovascular benefits and appears to reduce the risk of …
Results of Wegovy's longest clinical trial on weight loss ... - CTV News
May 14, 2024 · Almost 23 per cent of people on Wegovy lost at least 15 per cent of their body weight, compared with 1.7 per cent on a placebo.
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
Nov 11, 2023 · The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.
Wegovy users keep weight off for 4 years, new analysis finds - NBC News
May 14, 2024 · Reuters. Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments...
Trial confirms heart benefits of Wegovy, but is weight loss ... - CNN
Nov 11, 2023 · Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related...
Wegovy Moves Beyond Weight Loss - The New York Times
Mar 11, 2024 · Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are...
Wegovy weight-loss drug reduced risk of serious heart ... - CBS News
Nov 13, 2023 · The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20%, according to a large, international study paid for by Novo Nordisk, the drugmaker behind the product.
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.